Prediction of severe illness due to COVID-19 based on an analysis of initial Fibrinogen to Albumin Ratio and Platelet count

Concomitant coagulation disorder can occur in severe patients withCOVID-19, but in-depth studies are limited. This study aimed to describe the parameters of coagulation function of patients with COVID-19 and reveal the risk factors of developing severe disease. This study retrospectively analyzed 11...

Full description

Bibliographic Details
Main Authors: Xiaojie Bi, Zhengxian SU, Haixi Yan, Juping Du, Jing Wang, Linping Chen, Minfei Peng, Shiyong Chen, Bo Shen, Jun Li
Format: Article
Language:English
Published: Taylor & Francis Group 2020-07-01
Series:Platelets
Subjects:
Online Access:http://dx.doi.org/10.1080/09537104.2020.1760230
_version_ 1797684228754767872
author Xiaojie Bi
Zhengxian SU
Haixi Yan
Juping Du
Jing Wang
Linping Chen
Minfei Peng
Shiyong Chen
Bo Shen
Jun Li
author_facet Xiaojie Bi
Zhengxian SU
Haixi Yan
Juping Du
Jing Wang
Linping Chen
Minfei Peng
Shiyong Chen
Bo Shen
Jun Li
author_sort Xiaojie Bi
collection DOAJ
description Concomitant coagulation disorder can occur in severe patients withCOVID-19, but in-depth studies are limited. This study aimed to describe the parameters of coagulation function of patients with COVID-19 and reveal the risk factors of developing severe disease. This study retrospectively analyzed 113patients with SARS-CoV-2 infection in Taizhou Public Health Center. Clinical characteristics and indexes of coagulation function were collected. A multivariate Cox analysis was performed to identify potential biomarkers for predicting disease progression. Based on the results of multivariate Cox analysis, a Nomogram was built and the predictive accuracy was evaluated through the calibration curve, decision curve, clinical impact curve, and Kaplan–Meier analysis. Sensitivity, specificity, predictive values were calculated to assess the clinical value. The data showed that Fibrinogen, FAR, and D-dimer were higher in the severe patients, while PLTcount, Alb were much lower. Multivariate Cox analysis revealed that FAR and PLT count were independent risk factors for disease progression. The optimal cutoff values for FAR and PLT count were 0.0883 and 135*109/L, respectively. The C-index [0.712 (95% CI = 0.610–0.814)], decision curve, clinical impact curve showed that Nomogram could be used to predict the disease progression. In addition, the Kaplan–Meier analysis revealed that potential risk decreased in patients with FAR<0.0883 and PLT count>135*109/L.The model showed a good negative predictive value [(0.9474 (95%CI = 0.845–0.986)].This study revealed that FAR and PLT count were independent risk factors for severe illness and the severity of COVID-19 might be excluded when FAR<0.0883 and PLT count>135*109/L.
first_indexed 2024-03-12T00:26:38Z
format Article
id doaj.art-d4a90647e43447f5be87715838268fe0
institution Directory Open Access Journal
issn 0953-7104
1369-1635
language English
last_indexed 2024-03-12T00:26:38Z
publishDate 2020-07-01
publisher Taylor & Francis Group
record_format Article
series Platelets
spelling doaj.art-d4a90647e43447f5be87715838268fe02023-09-15T10:38:07ZengTaylor & Francis GroupPlatelets0953-71041369-16352020-07-0131567467910.1080/09537104.2020.17602301760230Prediction of severe illness due to COVID-19 based on an analysis of initial Fibrinogen to Albumin Ratio and Platelet countXiaojie Bi0Zhengxian SU1Haixi Yan2Juping Du3Jing Wang4Linping Chen5Minfei Peng6Shiyong Chen7Bo Shen8Jun Li9Wenzhou Medical UniversityWenzhou Medical UniversityWenzhou Medical UniversityWenzhou Medical UniversityWenzhou Medical UniversityWenzhou Medical UniversityWenzhou Medical UniversityWenzhou Medical UniversityWenzhou Medical UniversityWenzhou Medical UniversityConcomitant coagulation disorder can occur in severe patients withCOVID-19, but in-depth studies are limited. This study aimed to describe the parameters of coagulation function of patients with COVID-19 and reveal the risk factors of developing severe disease. This study retrospectively analyzed 113patients with SARS-CoV-2 infection in Taizhou Public Health Center. Clinical characteristics and indexes of coagulation function were collected. A multivariate Cox analysis was performed to identify potential biomarkers for predicting disease progression. Based on the results of multivariate Cox analysis, a Nomogram was built and the predictive accuracy was evaluated through the calibration curve, decision curve, clinical impact curve, and Kaplan–Meier analysis. Sensitivity, specificity, predictive values were calculated to assess the clinical value. The data showed that Fibrinogen, FAR, and D-dimer were higher in the severe patients, while PLTcount, Alb were much lower. Multivariate Cox analysis revealed that FAR and PLT count were independent risk factors for disease progression. The optimal cutoff values for FAR and PLT count were 0.0883 and 135*109/L, respectively. The C-index [0.712 (95% CI = 0.610–0.814)], decision curve, clinical impact curve showed that Nomogram could be used to predict the disease progression. In addition, the Kaplan–Meier analysis revealed that potential risk decreased in patients with FAR<0.0883 and PLT count>135*109/L.The model showed a good negative predictive value [(0.9474 (95%CI = 0.845–0.986)].This study revealed that FAR and PLT count were independent risk factors for severe illness and the severity of COVID-19 might be excluded when FAR<0.0883 and PLT count>135*109/L.http://dx.doi.org/10.1080/09537104.2020.1760230coagulation and fibrinolysiscovid-19fibrinogen-to-albumin ratio (far)non-severe survival (nss)platelet count (plt)prediction
spellingShingle Xiaojie Bi
Zhengxian SU
Haixi Yan
Juping Du
Jing Wang
Linping Chen
Minfei Peng
Shiyong Chen
Bo Shen
Jun Li
Prediction of severe illness due to COVID-19 based on an analysis of initial Fibrinogen to Albumin Ratio and Platelet count
Platelets
coagulation and fibrinolysis
covid-19
fibrinogen-to-albumin ratio (far)
non-severe survival (nss)
platelet count (plt)
prediction
title Prediction of severe illness due to COVID-19 based on an analysis of initial Fibrinogen to Albumin Ratio and Platelet count
title_full Prediction of severe illness due to COVID-19 based on an analysis of initial Fibrinogen to Albumin Ratio and Platelet count
title_fullStr Prediction of severe illness due to COVID-19 based on an analysis of initial Fibrinogen to Albumin Ratio and Platelet count
title_full_unstemmed Prediction of severe illness due to COVID-19 based on an analysis of initial Fibrinogen to Albumin Ratio and Platelet count
title_short Prediction of severe illness due to COVID-19 based on an analysis of initial Fibrinogen to Albumin Ratio and Platelet count
title_sort prediction of severe illness due to covid 19 based on an analysis of initial fibrinogen to albumin ratio and platelet count
topic coagulation and fibrinolysis
covid-19
fibrinogen-to-albumin ratio (far)
non-severe survival (nss)
platelet count (plt)
prediction
url http://dx.doi.org/10.1080/09537104.2020.1760230
work_keys_str_mv AT xiaojiebi predictionofsevereillnessduetocovid19basedonananalysisofinitialfibrinogentoalbuminratioandplateletcount
AT zhengxiansu predictionofsevereillnessduetocovid19basedonananalysisofinitialfibrinogentoalbuminratioandplateletcount
AT haixiyan predictionofsevereillnessduetocovid19basedonananalysisofinitialfibrinogentoalbuminratioandplateletcount
AT jupingdu predictionofsevereillnessduetocovid19basedonananalysisofinitialfibrinogentoalbuminratioandplateletcount
AT jingwang predictionofsevereillnessduetocovid19basedonananalysisofinitialfibrinogentoalbuminratioandplateletcount
AT linpingchen predictionofsevereillnessduetocovid19basedonananalysisofinitialfibrinogentoalbuminratioandplateletcount
AT minfeipeng predictionofsevereillnessduetocovid19basedonananalysisofinitialfibrinogentoalbuminratioandplateletcount
AT shiyongchen predictionofsevereillnessduetocovid19basedonananalysisofinitialfibrinogentoalbuminratioandplateletcount
AT boshen predictionofsevereillnessduetocovid19basedonananalysisofinitialfibrinogentoalbuminratioandplateletcount
AT junli predictionofsevereillnessduetocovid19basedonananalysisofinitialfibrinogentoalbuminratioandplateletcount